News

Pharmabiz37m
Intas Pharma & Accord BioPharma become one of the largest global suppliers of pegfilgrastim with acquisition of Udenyca
Our Bureau, Mumbai Friday, August 8, 2025, 14:15 Hrs [IST] ...
Pharmabiz6h
NPPA accepts MDC's decision to reject Dr Reddy's application on separate price for Omaze ODT
Gireesh Babu, New Delhi Friday, August 8, 2025, 08:00 Hrs [IST] ...
Pharmabiz52m
CorMedix to acquire biopharma company, Melinta Therapeutics in $300 million deal
CorMedix to acquire biopharma company, Melinta Therapeutics in $300 million deal: Berkeley Heights, New Jersey Friday, August 8, 2025, 14:00 Hrs [IST] CorMedix Inc. (CorMedix), a ...
Pharmabiz6h
CDSCO cancels Indian agent's import registration for cosmetic products of Proteos Biotech
CDSCO cancels Indian agent's import registration for cosmetic products of Proteos Biotech: Our Bureau, New Delhi Friday, ...
Pharmabiz1h
Cartherics opens state-of-the-art cleanroom facility for clinical-scale manufacturing of cell therapy products
Cartherics opens state-of-the-art cleanroom facility for clinical-scale manufacturing of cell therapy products: Melbourne, Australia Friday, August 8, 2025, 13:00 Hrs [IST] Melbou ...
Pharmabiz1h
Biocon net profit down 95 per cent in Q1FY26
Our Bureau, New Delhi Friday, August 8, 2025, 13:30 Hrs [IST] Biopharmaceutical major Biocon Ltd has reported a 95 per cent decline i ...
Pharmabiz2h
Cardiol Therapeutics reports topline results from phase II ARCHER trial of CardiolRx in acute myocarditis patients
Cardiol Therapeutics reports topline results from phase II ARCHER trial of CardiolRx in acute myocarditis patients: Toronto, Ontario Friday, August 8, 2025, 12:00 Hrs [IST] Cardio ...
Pharmabiz4h
Freenome enters exclusive license agreement with Exact Sciences to commercialize Freenome’s blood-based screening test for colorectal cancer
Brisbane, California Friday, August 8, 2025, 10:00 Hrs [IST] ...
Pharmabiz3h
US FDA approves Jazz Pharmaceuticals’ Modeyso to treat recurrent H3 K27M-mutant diffuse midline glioma
US FDA approves Jazz Pharmaceuticals’ Modeyso to treat recurrent H3 K27M-mutant diffuse midline glioma: Dublin Friday, August 8, 2025, 11:00 Hrs [IST] Jazz Pharmaceuticals plc, ...
Pharmabiz5h
Eli Lilly announces positive results from phase 3 ATTAIN-1 trial of orforglipron, an oral GLP-1 receptor agonist to treat obesity
Eli Lilly announces positive results from phase 3 ATTAIN-1 trial of orforglipron, an oral GLP-1 receptor agonist to treat obesity: Indianapolis Friday, August 8, 2025, 09:00 Hrs [ ...
Pharmabiz6h
Pioneer Poonam Pharma LLP to be launched at Thrissur in Kerala on August 20
Pioneer Poonam Pharma LLP to be launched at Thrissur in Kerala on August 20: Peethaambaran Kunnathoor, Chennai Friday, August 8, 2025, 08:00 Hrs [IST] ‘Pioneer Poonam Pharma LLP ...
Pharmabiz6h
Karnataka reduces withdrawal timeline for NSQ drugs from 30 days to just 3 days
Karnataka reduces withdrawal timeline for NSQ drugs from 30 days to just 3 days: Nandita Vijayasimha, Bengaluru Friday, August 8, 2025, 08:00 Hrs [IST] Karnataka government has ma ...